UniProt ID | NSDHL_HUMAN | |
---|---|---|
UniProt AC | Q15738 | |
Protein Name | Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating | |
Gene Name | NSDHL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 373 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass membrane protein . Lipid droplet . Trafficking through the Golgi is necessary for ER membrane localization. |
|
Protein Description | Involved in the sequential removal of two C-4 methyl groups in post-squalene cholesterol biosynthesis.. | |
Protein Sequence | MEPAVSEPMRDQVARTHLTEDTPKVNADIEKVNQNQAKRCTVIGGSGFLGQHMVEQLLARGYAVNVFDIQQGFDNPQVRFFLGDLCSRQDLYPALKGVNTVFHCASPPPSSNNKELFYRVNYIGTKNVIETCKEAGVQKLILTSSASVIFEGVDIKNGTEDLPYAMKPIDYYTETKILQERAVLGANDPEKNFLTTAIRPHGIFGPRDPQLVPILIEAARNGKMKFVIGNGKNLVDFTFVENVVHGHILAAEQLSRDSTLGGKAFHITNDEPIPFWTFLSRILTGLNYEAPKYHIPYWVAYYLALLLSLLVMVISPVIQLQPTFTPMRVALAGTFHYYSCERAKKAMGYQPLVTMDDAMERTVQSFRHLRRVK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEPAVSEP -------CCCCCCCC | 14.54 | 22223895 | |
19 | Phosphorylation | QVARTHLTEDTPKVN HHHHHHCCCCCCCCC | 24.98 | 29214152 | |
19 | O-linked_Glycosylation | QVARTHLTEDTPKVN HHHHHHCCCCCCCCC | 24.98 | OGP | |
22 | Phosphorylation | RTHLTEDTPKVNADI HHHCCCCCCCCCCCH | 20.83 | 21129721 | |
24 | Ubiquitination | HLTEDTPKVNADIEK HCCCCCCCCCCCHHH | 50.65 | - | |
31 | Ubiquitination | KVNADIEKVNQNQAK CCCCCHHHCCHHHHC | 46.98 | 21906983 | |
31 | Acetylation | KVNADIEKVNQNQAK CCCCCHHHCCHHHHC | 46.98 | 26051181 | |
31 | 2-Hydroxyisobutyrylation | KVNADIEKVNQNQAK CCCCCHHHCCHHHHC | 46.98 | - | |
38 | 2-Hydroxyisobutyrylation | KVNQNQAKRCTVIGG HCCHHHHCCCEEECC | 37.94 | - | |
87 | Phosphorylation | FFLGDLCSRQDLYPA HHHHHHHCHHHHHHH | 40.03 | 21712546 | |
96 | Ubiquitination | QDLYPALKGVNTVFH HHHHHHHCCCCEEEE | 64.02 | 21890473 | |
96 | Acetylation | QDLYPALKGVNTVFH HHHHHHHCCCCEEEE | 64.02 | 26051181 | |
106 | Phosphorylation | NTVFHCASPPPSSNN CEEEEECCCCCCCCC | 43.25 | 30266825 | |
110 | Phosphorylation | HCASPPPSSNNKELF EECCCCCCCCCCEEE | 52.01 | 23312004 | |
114 | Acetylation | PPPSSNNKELFYRVN CCCCCCCCEEEEEEE | 61.11 | 26051181 | |
114 | Ubiquitination | PPPSSNNKELFYRVN CCCCCCCCEEEEEEE | 61.11 | - | |
122 | Phosphorylation | ELFYRVNYIGTKNVI EEEEEEEEEECHHHH | 9.62 | 28152594 | |
126 | Ubiquitination | RVNYIGTKNVIETCK EEEEEECHHHHHHHH | 43.96 | - | |
126 | 2-Hydroxyisobutyrylation | RVNYIGTKNVIETCK EEEEEECHHHHHHHH | 43.96 | - | |
126 | Malonylation | RVNYIGTKNVIETCK EEEEEECHHHHHHHH | 43.96 | 26320211 | |
126 | Acetylation | RVNYIGTKNVIETCK EEEEEECHHHHHHHH | 43.96 | 26051181 | |
133 | 2-Hydroxyisobutyrylation | KNVIETCKEAGVQKL HHHHHHHHHHCCEEE | 59.00 | - | |
133 | Ubiquitination | KNVIETCKEAGVQKL HHHHHHHHHHCCEEE | 59.00 | - | |
147 | Phosphorylation | LILTSSASVIFEGVD EEEECCCEEEEECCC | 20.07 | - | |
159 | Phosphorylation | GVDIKNGTEDLPYAM CCCCCCCCCCCCCCC | 35.40 | 21406692 | |
164 | Phosphorylation | NGTEDLPYAMKPIDY CCCCCCCCCCCCCCE | 26.99 | 20068231 | |
167 | Ubiquitination | EDLPYAMKPIDYYTE CCCCCCCCCCCEEHH | 30.56 | - | |
171 | Phosphorylation | YAMKPIDYYTETKIL CCCCCCCEEHHHHHH | 17.01 | 21406692 | |
172 | Phosphorylation | AMKPIDYYTETKILQ CCCCCCEEHHHHHHH | 8.37 | 21406692 | |
173 | Phosphorylation | MKPIDYYTETKILQE CCCCCEEHHHHHHHH | 30.83 | 21406692 | |
175 | Phosphorylation | PIDYYTETKILQERA CCCEEHHHHHHHHHH | 18.65 | 21406692 | |
176 | Ubiquitination | IDYYTETKILQERAV CCEEHHHHHHHHHHH | 34.88 | - | |
191 | Ubiquitination | LGANDPEKNFLTTAI HCCCCHHCCCEECCC | 59.39 | 21890473 | |
232 | Ubiquitination | KFVIGNGKNLVDFTF EEEECCCCCCEEEEE | 51.62 | - | |
263 | Ubiquitination | RDSTLGGKAFHITND CCCCCCCEEEEECCC | 46.19 | - | |
284 | Phosphorylation | TFLSRILTGLNYEAP HHHHHHHHCCCCCCC | 36.93 | 20068231 | |
288 | Phosphorylation | RILTGLNYEAPKYHI HHHHCCCCCCCCCCH | 20.64 | - | |
293 | Phosphorylation | LNYEAPKYHIPYWVA CCCCCCCCCHHHHHH | 12.15 | 23401153 | |
297 | Phosphorylation | APKYHIPYWVAYYLA CCCCCHHHHHHHHHH | 16.35 | 23401153 | |
308 | Phosphorylation | YYLALLLSLLVMVIS HHHHHHHHHHHHHHH | 21.45 | 23401153 | |
345 | Ubiquitination | YSCERAKKAMGYQPL EEHHHHHHHCCCCCE | 42.49 | - | |
349 | Phosphorylation | RAKKAMGYQPLVTMD HHHHHCCCCCEEEHH | 8.22 | - | |
354 | Phosphorylation | MGYQPLVTMDDAMER CCCCCEEEHHHHHHH | 23.67 | 29978859 | |
362 | Phosphorylation | MDDAMERTVQSFRHL HHHHHHHHHHHHHHH | 15.02 | 29978859 | |
365 | Phosphorylation | AMERTVQSFRHLRRV HHHHHHHHHHHHHCC | 21.66 | 22468782 | |
537 | Ubiquitination | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NSDHL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NSDHL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NSDHL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CCHL_HUMAN | HCCS | physical | 27173435 | |
COMT_HUMAN | COMT | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00496 | Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD) | |||||
H00577 | Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Part | |||||
OMIM Disease | ||||||
308050 | Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) | |||||
300831 | CK syndrome (CKS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...